Stay updated on KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer's site revision identifier changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:44:55.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.” The study page itself displays a 403 error.
    Difference
    1%
    Check dated 2026-10-24T19:37:31.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T20:41:57.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0. The page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T20:50:41.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating access is blocked to the study record, replacing the previous content. The additions show the 403 header/footer and navigation, while extensive study-related items and documents appear to have been removed or hidden.
    Difference
    18%
    Check dated 2026-09-19T22:27:33.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.6.6 was added and Revision: v3.6.5 was removed, indicating the page has been updated to a new revision. The update represents a version change of the page rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-08-29T20:54:27.000Z thumbnail image

Stay in the know with updates to KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KeyLargo: Pembrolizumab Combo in Gastric Cancer Clinical Trial page.